Viewing nowHanwha Rasagiline Tablet 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201908458 · Approved 2019.12.17
Treatment of idiopathic Parkinson's disease
This medication is indicated for the treatment of idiopathic Parkinson's disease. Initially, dopamine agonists are used alone or in combination with other medications as an adjunct therapy. Additionally, if motor dyskinesia symptoms occur, levodopa may be added as an adjunct therapy. This treatment method helps improve the motor symptoms of Parkinson's disease and facilitates the patient's daily life.
This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medication should not be taken by individuals allergic to specific ingredients. Caution is advised when taken in conjunction with other MAO inhibitors or certain pain medications and cough syrups, as there may be risks involved. Patients with severely impaired liver function should not take this medication. During treatment, various side effects such as cold, headache, dizziness, nausea, skin rash, etc., may arise. This medication is used for the treatment of Parkinson's disease and can cause side effects such as dystonia or lowered blood pressure. Drowsiness or sudden sleep may occur during treatment, so caution is advised when driving or operating dangerous machinery. Additionally, there are many interactions between this medication and other drugs, so patients must consult with their doctor or pharmacist if they are taking other medications. If pregnant or breastfeeding, it's essential to consult with healthcare professionals before using this medication. Particular caution is needed for children and elderly patients aged 65 and older, and dosage adjustment may be required. In case of overdose, severe side effects may occur, so it is crucial to adhere to the prescribed dosage. This medication should be stored in a cool place out of reach of children, and it is advisable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture; therefore, it must be stored in a sealed container. It is important to maintain the storage temperature between 1°C and 25°C to preserve the drug's effectiveness and safety over time.
White, round tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.